Voglismile 0.3 Tab

Composition

Metformin (500mg) + Voglibose (0.2mg)

Uses of Voglismile 0.3 Tab

Management of type 2 diabetes mellitus to reduce post‑meal (postprandial) blood glucose; used alone or with other antidiabetic medicines along with diet and exercise.

• •Reduces post-meal blood sugar spikes
• •Improves overall glycaemic control in type 2 diabetes
• •Can be combined with other antidiabetic medicines
• •Helps support diet-based glucose control

How it works

Voglibose is an alpha‑glucosidase inhibitor that delays breakdown and absorption of carbohydrates in the small intestine. This reduces the rise in blood glucose after meals.

Directions for use

Take by mouth just before meals (typically immediately before the first bite of food) as prescribed by the doctor. If you skip a meal, skip the dose. Continue diet and exercise advice; monitor blood sugar regularly.

Side effects

Common side effects of Voglismile 0.3 Tab may include:

• •Flatulence
• •abdominal pain
• •diarrhea
• •bloating
• •nausea

Warnings & precautions

Not for type 1 diabetes or diabetic ketoacidosis. Use with caution in kidney or liver disease and in elderly patients. Avoid/use caution in inflammatory bowel disease, colonic ulceration, intestinal obstruction or predisposition to obstruction. Risk of hypoglycaemia increases when used with insulin or sulfonylureas—carry glucose (dextrose) for treatment as sucrose absorption may be delayed. Seek medical help for severe abdominal pain, persistent diarrhea, or signs of liver injury (yellowing of eyes/skin, dark urine).